Search

everythinglearnresearchcommunity

for

Search:↓

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Arabidopsis Formin 2 stabilizes actin filaments, affecting cell-to-cell movement and virus susceptibility.

The laser system helps study brain cell functions by precisely removing specific cells and observing changes.

Targeting ornithine decarboxylase can help prevent skin cancer.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

Chlorinated compounds like TCDD can cause skin issues and chloracne by affecting cell behavior.

CAP1/Prss8 does not activate PAR2 or inhibit PN-1.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Pregnancy-related hormone changes affect Y1 receptor gene expression in mice.

Meis2 is essential for touch sensation and nerve function in mice.

Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.

New probes were created to effectively measure specific enzymes involved in fat metabolism, which could help develop new drugs.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

Suppressing ODC activity reduces tumor growth in hair follicles.

ERK activation spreads between cells in mouse skin, linked to cell division and influenced by TPA and EGF receptors.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

ETS2 drives cancer progression in squamous cell carcinoma and is linked to poor patient outcomes.

The protein's size was reduced, but more work is needed to confirm its function.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

A new compound was made to detect copper ions effectively.

A specific protein complex increases the activity of a plant enzyme, but this action is not required for plant root hair growth.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

Certain alkaloids could help create new coronavirus drugs.

miR-22 helps skin cancer grow and spread by activating specific cell signals.